Clinical Trial Update: Bioequivalence Study of Generic Tretinoin 0.04% Microsphere Gel, 0.04% Retin-A Micro® and Placebo [Phase 3]

View source ↗

Summary

Phase 3 bioequivalence study comparing generic tretinoin 0.04% microsphere gel to Retin-A Micro and placebo in acne, completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne

Drugs mentioned

• RETIN-A MICRO (TRETINOIN)
• Tretinoin 0.04% microsphere gel (tretinoin)

Snippet

Sponsor: Spear Pharmaceuticals | Conditions: Acne | Phase 3 | Status: COMPLETED | Results posted: 2014-11-18